Site- and mechanism-targeted interventions for tissue free radical injury

Chronic Lung Disease in Early Infancy

Volumn , Issue , 1999, Pages 883-910

  Berrington, William R ^a   Tarpey, Margaret M ^a   Freeman, Bruce A ^a   Pitt, Bruce R ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013270920     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (136)

1. Gryglewski R, Palmer R, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320:454-456.
2. Huie RE, Padmaja S. Reaction of NO with O/~. Free Radic Res Commun 1993; 18:195-199.
3. Padmaja S, Huie RE. The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun 1993; 195:539-544.
4. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268:L699-L722.
5. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-1624.
6. Radi R, Beckman JS, Bush K, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of endothelial-derived superoxide and nitric oxide. J Biol Chem 1991; 266:4244-4250.
7. Van der Vliet A, Smith D, O’Neill CA, Kaur H, Darley-Usmar VM, Cross CE, Halliwell B. Interactions of peroxynitrite with human plasma and its constituents. Oxidative damage and antioxidant depletion. Biochem J 1994; 303:295-301.
8. Radi R, Cosgrove T, Beckman JS, Freeman BA. Peroxynitrite-induced luminol chemiluminescence. Biochem J 1993; 290:51-57.
9. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. The oxidation of a-tocoph- erol in human low density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett 1993; 326:199-203.
10. Castro L, Rodriguez M, Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J Biol Chem 1994; 269:29409-29415.
11. Matheis G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992; 262:H616-H620.
12. Mulligan MS, Warren JS, Smith CW, Anderson DC, Yeh CG, Rudolph AR, Ward PA. Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine. J Immunol 1992; 148:3086-3092.
13. Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992; 298:452-457.
14. Denicola A, Rubbo H, Rodriguez D, Radi R. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys 1993; 304:279-286.
15. Carreras MC, Pargament GA, Catz SD, Poderoso JJ, Boveris A. Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett 1994; 341:65-68.
16. Radi R, Rodriguez M, Castro L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89-95.
17. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanism of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265:L555-L564.
18. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 1994; 375:81-88.
19. White R, Brock T, Chang L, Crapo J, Briscoe P, Ku D, Bradley W, Gianturco S, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91:1044-1048.
20. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys 1994; 310:352-359.
21. Wink DA, Osawa Y, Darbyshire J, Jones CR, Eshenaur S, Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys 1993; 300:115-123.
22. Schmidt HH, Walter U. NO at work. Cell 1994; 78:919-925.
23. Snyder SH. Nitric oxide: first in a new class of neurotransmitters? Science 1993; 257:494-496.
24. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94.
25. Lepoivre M, Flaman J, Bobe P, Lemaire G, Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide: relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994; 269:21891-21897.
26. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345:50-54.
27. Schweizer M, Richter C. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 1994; 204:169-175.
28. Takehara Y, Kanno T, Yoshioka T, Inoue M, Utsumi K. Oxygen dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch Biochem Biophys 1995; 323:27-32.
29. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome c oxidase. FEBS Lett 1994; 356:295-298.
30. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiov Dis 1995; 38:87-104.
31. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. N Horizons 1995; 3:46-64.
32. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269:26066-26075.
33. Rubbo H, Parthasarathy S, Kalyanaraman B, Barnes S, Kirk M, Freeman BA. Nitric oxide inhibition of lipoxygenase-dependent liposome and low density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 1995; 324:1525.
34. Chumley P, Rubbo H, Gutierrez HH, Freeman BA. Nitric oxide regulation of superoxide, hydrogen peroxide, and peroxynitrite-dependent injury to vascular endothelium. Free Radic Biol Med 1997; (submitted).
35. Liebler DC. The role of metabolism in the antioxidant function of vitamin E. Crit Rev Toxicol 1993; 23:147-169.
36. Goss SP, Hogg N, Kalyanaraman B. The antioxidant effect of spermine NONOate in human low density lipoprotein. Chem Res Toxicol 1995; 8:800-806.
37. Rubbo H, Paler-Martinez A, Chumley P, Kirk M, Barnes B, Freeman BA. Nitric oxide and a-tocopherol react to inhibit lipid oxidation: termination of propagation reactions and recovery of reduced a-tocopherol. J Biol Chem 1996; (submitted).
38. Gutierrez H, Chumley P, Rivera A, Freeman BA. Nitric oxide regulation of superoxide-dependent lung cell injury: oxidant-protective actions of endogenously produced and exogenously administrated nitric oxide. Free Radic Biol Med 1996; 21: 43-52.
39. Miller RA, Britigan BE. The formation and biologic significance of phagocyte- derived oxidants. J Invest Med 1995; 43:39-49.
40. Albina JE, Reichner JS. Nitric oxide in inflammation and immunity. N Horizons 1995; 3:46-64.
41. Clancy RM, Leszczynska J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90:1116-1121.
42. Wiedermann CJ, Sitte B, Zilian U, Reinisch N, Beimpold H, Finkenstedt G, Braun- steiner H. Inhibition of superoxide anion release from circulating neutrophils by L-arginine in man. Clin Invest 1993; 71:985-989.
43. Rubanyi GM, Ho E, Cantor E, Lumma W, Parker LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991; 181:1392-1397.
44. Rossaint R, Gerlach H, Falke KJ. Inhalation of nitric oxide—a new approach in severe ARDS. Eur J Anesthesiol 1994; 11:43-51.
45. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256:10986-10992.
46. Kavanagh BP, Mouchawar A, Goldsmith J, Pearl RG. Effects of inhaled nitric oxide and inhibition of endogenous nitric oxide synthesis in oxidant-induced acute lung injury. J Appl Physiol 1994; 76:1324-1329.
47. Chollet-Martin S, Gatecel C, Kermarrec N, Gougerot-Pocidalo MA, Payen DM. Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153:985-990.
48. Mercer RR, Costa DL, Crapo JD. Effects of prolonged exposure to low doses of nitric oxide or nitrogen dioxide on the alveolar septa of the adult rat lung. Lab Invest 1995; 73:20-28.
49. Haddad IY, Crow J, Hu P, Ye Y, Beckman JS, Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol 1994; 267:L242-L249.
50. Kooy N, Royall J, Ye Y, Kelly D, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-1254.
51. Ahluwalia JS, Kelsall A, Raine J, Rennie JM, Mahmoo, Oduro A, Latimer R, Pickett J, Higenbottam TW. Safety of inhaled nitric oxide in premature neonates. Acta Pediatr 1994; 83:347-348.
52. Griscavage JM, Fukuto J, Komori Y, Ignarro LJ. Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. J Biol Chem 1994; 269:21644-21649.
53. Harrison DG, Freiman PC, Armstrong ML, Marcus ML, Heistad DD. Alterations in vascular reactivity in atherosclerosis. Circ Res 1987; 61:74-80.
54. Jayakody L, Senaratne M, Thomson A, Kappagoda T. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 1987; 60:251-264.
55. Rossaint R, Falke K, Lopez F, Slama K, Pison U, Zapol W. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
56. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger G, Fikrle A, Ballmer P, Nicod P, Bartsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996; 334:624-629.
57. Pryor WA, Jin X, Squadrito GL. One- and two-electron oxidations of methionine by peroxynitrite. Proc Natl Acad Sci USA 1994; 91:11173-11177.
58. Salgo MG, Stone K, Squadrito GL, Battista JR, Pryor WA. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochem Biophys Res Commun 1995; 210:1025-1030.
59. Darley-Usmar VM, Hogg N, O’Leary VJ, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low-density lipoproteins. Free Radic Res Commun 1993; 17:19-20.
60. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995; 92:6264-6268.
61. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular-superoxide dismutase. Ar- terioscler Thromb Vasc Biol 1995; 15:2032-2036.
62. Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 1996; 20:957-965.
63. Sandstrom J, Carlsson L, Marklund S, Edlund T. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem 1992; 267:18205-18209.
64. Edlund A, Edlund T, Hjalmarsson K, Marklund SL, Sandstrom J, Stromqvist M, Tibell L. A non-glycosylated extracellular superoxide dismutase variant. Biochem J 1992; 288:451-456.
65. Karlsson K, Edlund A, Sandstrom J, Marklund SL. Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase. Biochem J 1993; 290:623-626.
66. Maridonneau-Parini I, Tringale SM, Tauber AI. Identification of distinct activation pathways of the human neutrophil NADPH-oxidase. J Immunol 1986; 137:2925-2929.
67. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils: release and interaction with superoxide anion. Biochem J 1989; 261:293-296.
68. Marklund SL. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J Biol Chem 1992; 267: 6696-670.
69. Oury TD, Chang L-Y, Marklund SL, Day BJ, Crapo JD. Imunohistochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 889-898.
70. Monboisse J-C, Gardes-Albert M, Randoux A, Borel J-P, Ferradini C. Non-enzy- matic degradation of acid-soluble calf skin collagen by superoxide ion: protective effect of flavonoids. Biochem Pharmacol 1983; 32:53-58.
71. Riley DJ, Kerr JS, Laskin DL, Guss HN, Curran SF, Berg RA. Intratracheal instillation of collagen peptides induces a neutrophil influx in rat lungs. Trans Assoc Am Physicians 1984; 97:290-295.
72. Hansson L, Edlund M, Edlund A, Johansson T, Marklund SL, Fromm S, Stromqvist M, Tcirnell J. Expression and characterization of biologically active human extracellular superoxide dismutase in milk of transgenic mice. J Biol Chem 1994; 269: 5358-5363.
73. Boissinot M, Kuhn LA, Lee P, Fisher CL, Wang Y, Hallewell RA, Tainer JA. Rational design and expression of a heparin-targeted human superoxide dismutase. Biochem Biophys Res Commun 1993; 190:250-256.
74. Miinzel T, Kurz S, Rajagopalan S, Thoenes M, Berrington WR, Thompson JA, Freeman BA, Harrison DG. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: anew action for an old drug. J Clin Invest 1996; 98:1465-1470.
75. Inoue M, Watanabe N, Matsuno K, Sasaki J, Tanaka Y, Hatanaka H, Amachi T. Expression of a hybrid Cu/Zn-type superoxide dismutase which has high affinity for heparin-like proteoglycans on vascular endothelial cells. J Biol Chem 1991; 266:16409-16414.
76. Abrahamsson T, Brandt U, Marklund SL, Sjoqvist P-O. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals in endothelium-dependent arterial relaxation. Circ Res 1992; 70:264-271.
77. Sjoquist P-O, Marklund SL. Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts. Cardiovasc Res 1992; 26:347-350.
78. Kohen R, Kakunda A, Rubinstein A. The role of cationized catalase and cationized glucose oxidase in mucosal oxidative damage induced in the rat jejunum. J Biol Chem 1992; 267:21349-21354.
79. Salin ML, McCord JM. Free radicals and inflammation. Protection of phagocytos-ing leukocytes by superoxide dismutase. J Clin Invest 1975; 56:1319-1323.
80. Schalkwijk J, Van den Berg WB, Van de Putte LB, Joosten LA, Van den Bersselaar L. Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J Clin Invest 1985; 76:198-205.
81. White CW, Jackson JH, Abuchowski A, Kazo GM, Mimmack RF, Berger EM, Freeman BA, McCord JM, Repine JE. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J Appl Physiol 1989; 66:584-590.
82. Pyatak PS, Abuchowski A, Davis FF. Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and antiinflammatory activity. Res Commun Chem Pathol Pharmacol 1980; 29:113-127.
83. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 1977; 252:3582-3586.
84. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 1977; 252:3578-3581.
85. Boni LT, Hah JS, Hui SW, Mukherjee P, Ho JT, Jung CY. Aggregation and fusion of unilamellar vesicles by poly(ethylene glycol). Biochim Biophys Acta 1984; 775: 409-418.
86. Beckman JS, Minor RL Jr, White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 1988; 263:6884-6892.
87. Tang G, White JE, Gordon RJ, Lumb PD, Tsan MF. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. J Appl Physiol 1993; 74:1425-1431.
88. Walther FJ, Nunez FL, David-Cu R, Hill KE. Mitigation of pulmonary oxygen toxicity in rats by intratracheal instillation of polyethylene glycol-conjugated antioxidant enzymes. Pediatr Res 1993; 33(pt 1):332-335.
89. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycol- conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989; 256(pt 1):H589-H593.
90. Hiraoka Y, Kishimoto C, Takada H, Kurokawa M, Ochiai H, Shiraki K, Sasayama S. Role of oxygen derived free radicals.
91. Mihara K, Oka Y, Sawai K, Takakura Y, Hashida M. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol. J Drug Target 1994; 2:317-321.
92. Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 1991; 69:1293-1300.
93. Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 1996; 276: 538-543.
94. Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73:87-95.
95. Freeman BA, Turrens JF, Mirza Z, Crapo JD, Young SL. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 1985; 44:2591-2595.
96. Padmanabhan RV, Gudapaty R, Liener IE, Schwartz BA, Hoidal JR. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am Rev Respir Dis 1985; 132:164-167.
97. Walther FJ, David-Cu R, Lopez SL. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 1995; 269(pt 1):L613- L617.
98. Buckley BJ, Tanswell AK, Freeman BA. Liposome-mediated augmentation of cata- lase in alveolar type II cells protects against H2O2 injury. J Appl Physiol 1987; 63: 359-367.
99. Beckman JS, Minor RL Jr, Freeman BA. Augmentation of antioxidant enzymes in vascular endothelium. J Free Radic Biol Med 1986; 2:359-365.
100. Briscoe P, Caniggia I, Graves A, Benson B, Huang L, Tanswell AK, Freeman BA. Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am J Physiol 1995; 268(pt 1):L374-L380.
101. Collins D, Litzinger DC, Huang L. Structural and functional comparisons of pH- sensitive liposomes composed of phosphatidylethanolamine and three different di-acylsuccinylglycerols. Biochim Biophys Acta 1990; 1025:234-242.
102. White CR, Brock TA, Chang LY, Crapo JD, Briscoe P, Ku DD, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91:1044-1048.
103. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97:1916-1923.
104. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross tolerance. J Clin Invest 1995; 95:187-194.
105. Walther FJ, David-Cu R, Supnet MC, Longo ML, Fan BR, Bruni R. Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am J Physiol 1993; 265:L330-L339.
106. Woodle MC, Lasic DD. Sterically stabilized liposomes [review]. Biochim Biophys Acta 1992; 1113:171-199.
107. Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA. Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990; 1035:121-127.
108. Nieves-Cruz B, Rivera A, Cifuentes J, Pataki G, Matalon S, Carlo WA, Tanswell AK, Freeman BA. Clinical surfactant preparations mediate SOD and catalase uptake by type II cells and lung tissue. Am J Physiol 1996; 270:L659-L667.
109. Curiel DT, Pilewski JM, Albelda SM. Gene therapy approaches for inherited and acquired lung disease. Am J Respir Mol Cell Biol 1996; 14:1-18.
110. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270:404-410.
111. Alton EW, Geddes DM. Gene therapy for cystic fibrosis: a clinical perspective. Gene Ther 1995; 2:88-95.
112. Coutelle C, Douar A-M, Colledge WH, Proster U. The challenge of fetal gene therapy. Nature Med 1995; 1:864-866.
113. Pitt BR, Robbins PD. Fetal gene therapy. Retrovirus-mediated gene therapy to fetal lung. Hum Mol Reprod 1996; 2:467-469.
114. McCray PB Jr, Thomas P, Faasee T, Wang G, O’Brien L, Davidson BL. Proliferation indices of pulmonary epithelia during human lung development: targeting gene transfer with integrating vectors [abstr]. Am J Respir Crit Care Med 1996; 153: A115.
115. Sekhorn HS, Larson JE. In utero gene transfer into the pulmonary epithelium. Nature Med 1995; 1:1201-1203.
116. Holzinger A, Trapnell BC, Weaver TE, Whitsett JA, Iwamoto HS. Intra-amniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38:844-850.
117. McCray PB Jr, Armstrong K, Zabner J, Miller DW, Koretzky GA, Couture L, Ro- billard JE, Smith AE, Welsh MJ. Adeno-viral mediated gene transfer to fetal pulmonary epithelial in vitro and in vivo. J Clin Invest 1995; 95:2622-2632.
118. Vincent MC, Trapnell BC, Baughman RP, Weret SE, Whitsett JA, Iwamoto HS. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6:1019-1028.
119. Katkin J, Seidner S, Langston C, Welty S. Delivery of a recombinant adenovirus to the lungs of premature primates: safety and efficacy [abstr]. Am J Respir Crit Care Med 1996; 153:A113.
120. Niu J, Perry R, Siddig M, Davis J, Horowitz S, Simon S, Langenback E, Parton L. Aerosolized gene delivery to piglets with cationic liposomes [abstr]. Am J Respir Crit Care Med 1996; 153:A765.
121. Stribling R, Brunette E, Liggett D, Gaensler K, Debs R. Aerosol gene delivery in vivo. Proc Natl Acad Sci USA 1992; 89:11277-11281.
122. Logan JL, Bebok Z, Walker LC, Peng S, Felgner PL, Siegal GP, Frizzell RA, Dong J, Howard M, Matalon S, Lindsey JR, DuVall M, Sorscher EJ. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium. Gene Ther 1995; 2: 38-49.
123. Flotte TR, Afione SC, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Gug- gino WB, Carter BJ. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993; 90:10613-10617.
124. Zeitlin PL, Chu S, McVeigh U, Ferguson K, Flotte TR, Guggino WB. Alveolar stem cell transduction by an adenovirus-associated viral vector. Gene Ther 1995; 2:623-631.
125. Ezurum SC, Lemarchand P, Rosenfeld MA, Yoo JH, Crystal RG. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res 1993; 21:1607-1612.
126. Tzeng E, Kim Y-M, Pitt BR, Lizonova A, Kovesdi L, Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 1997; 122:255-263.
127. Wong HR, Mannix RJ, Rusnak JM, Boota A, Zar H, Watkins SC, Lazo JS, Pitt BR. The heat shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Respir Mol Cell Biol 1996; 15:745-751.
128. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR Jr, Pitt BR. Metallothionein protects against the cytotoxic and DNA damaging effects of nitric oxide. Proc Natl Acad Sci USA 1995; 92:4452-4456.
129. Conary JT, Parker RE, Christman BW, Faulks RD, King GA, Meyrick BO, Brigham KL. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J Clin Invest 1994; 93:1834-1840.
130. Canonico AE, Brigham KL, Carmichael LC, Plitman JD, King GA, Blackwell TR, Christman JW. Plasmid-liposome transfer of an a1 antitrypsin gene to cystic fibrosis bronchial epithelial cells prevents elastase-induced cell detachment and cytokine release. Am J Respir Cell Mol Biol 1996; 14:348-355.
131. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 1994; 91:215-219.
132. Peault B, Tirouvanziam R, Sombardier M-N, Chen S, Perricaudet M, Gaillard D. Gene transfer to human fetal pulmonary tissue developed in immunodeficient SCID mice. Hum Gene Ther 1994; 5:1131-1137.
133. Deutsch GH, Wright E, Robbins PD, DeLuca NA, Pitt BR, Pilewski JM. Gene transfer to adult and fetal human airway epithelia using replication-deficient pseudotyped retrovirus and herpes simplex virus-1 [abstr]. Am J Respir Crit Care Med 1996; 153:A115.
134. Ballard PL, Zepeda ML, Schwartz M, Lopez N, Wilson JM. Adenovirus-mediated gene transfer to human fetal lung, ex vivo. Am J Physiol 1995; 268:L839-L845.
135. Carlsson LM, Jonsson J, Edlund T, Marklund SL. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci USA 1995; 92:6264-6268.
136. Miyanohara A, Yee J-K, Bouic K, Laporte P, Friedmann T. Efficient in vivo transduction of the neonatal mouse liver with pseudotyped retroviral vectors. Gene Ther 1995; 2:138-142.